The study and its comparison
One blinded trial randomized 63 people with migraine to a multispecies probiotic or placebo for twelve weeks. It did not establish a benefit for migraine outcomes, intestinal permeability or inflammatory markers. [1][2]
Another randomized study reported 79 completers with episodic or chronic migraine using a fourteen-strain mixture. Headache-frequency and severity comparisons favored probiotics after eight or ten weeks, while inflammatory markers did not significantly change. [1][2]
What the finding establishes
Different preparations, follow-up periods and analysis populations complicate comparison. Completer results can be affected by who remains in a trial. Funding and conflicts were not established from the abstracts. Neither selecting only the favorable trial nor assuming all mixtures are equivalent fairly represents these findings; a mechanism involving gut permeability was not confirmed by both experiments. [1][2]
A hypothetical distinction
Imagine two probiotic mixtures give different trial results. The label category alone cannot identify which finding applies to another product.
| Detail | Interpretation |
|---|---|
| Measured outcome | Keep the endpoint specific |
| Study preparation | Not every retail product |
| Remaining uncertainty | Not resolved by a mechanism |
Sources for this article
- The effects of a multispecies probiotic on migraine and markers of intestinal permeability-results of a randomized placebo-controlled study.
Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product. - The effects of a multispecies probiotic supplement on inflammatory markers and episodic and chronic migraine characteristics: A randomized double-blind controlled trial.
Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.